VU0364572 (trifluoroacetate salt) 247egeline and β-adrenoceptors

and β-adrenoceptors

Tor and S6K that show high efficacy with very low toxicity

Receptor interacting protein-2 (RIP2) kinase

PLpro inhibitor display significant antiviral activity with EC50 values of 13

VU0364572 (trifluoroacetate salt) 247egeline and β-adrenoceptorsIC50: 477 172 nM VU0364572 is a M1 agonist. Alzheimer's disease (AD) is the leading cause of dementia worldwide, and no disease modifying therapy is availables. Selective M1 muscarinic acetylcholine receptor activation is an attractive mechanism for AD therapy since M1 mediates key effects on cognition, memory, and behavior and has potential for disease modifying effects on A formation and tau phosphorylation. In vitro: Previous study found that